Onkologie. 2018:12(5):242-246 | DOI: 10.36290/xon.2018.044

Antiemetic treatment in cancer patients

Petra Holečková1, Jana Gregorová2
1 1Ústav radiační onkologie, Nemocnice Na Bulovce a 1. LF UK, Praha
2 2Oddělení klinické farmacie, Nemocnice Na Bulovce, Praha, Ústav aplikované farmacie, Farmaceutická fakulta VFU, Brno, Ústav farmakologie, 2. lékařská fakulta UK, Praha

Nausea and vomiting belong to the most frequent adverse events of oncology treatment and also frequent symptoms accompanyingmalignant diseases, analgetics therapy or psychologic disorders. Often are seen in patients in palliative care. They aresymptoms which decrease qaulity od life, nutritional status and also performance status and can threat run of oncology treatment.Many antiemetics could be currently used. Important posibility of antiemetics is in their prophylactic use. It is necessary to findthe cause of these symptoms.

Keywords: nausea, vomiting, antiemetic treatment, oncology treatment

Published: October 15, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holečková P, Gregorová J. Antiemetic treatment in cancer patients. Onkologie. 2018;12(5):242-246. doi: 10.36290/xon.2018.044.
Download citation

References

  1. Lukáš K, Žák A. Chorobné znaky a příznaky: diferenciální diagnostika. Praha: Grada, 2014.
  2. Tomíška M, Vorlíček J. Nevolnost a zvracení v paliativní léčbě. Postgraduální medicína [online]. 2001, 15.3.2001, [cit. 2018-05-04]. Dostupné z: https://zdravi.euro.cz/clanek/postgradualni-medicina/nevolnost-a-zvraceni-v-paliativni-lecbe-134573.
  3. Aapro M, Gralla RJ, Herrstedt J, et al. MASCC/ESMO ANTIEMETIC GUIDELINE 2016 v.1.2. [online]. 2016, [cit. 2018-09-30]. Dostupné z: https://www.mascc.org/assets/Guidelines-Tools/mascc_antiemetic_guidelines_english_v.1.2.1.pdf.
  4. Antiemetics. NCCN guidelines, Inc.US [online]. 2018, 30-apr-2018, [cit. 2018-05-04]. Dostupné z: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf.
  5. Zásady prevence a léčby nevolnosti a zvracení po protinádorové léčbě. Modrá kniha [online]. 2018, 30-apr-2018, 177-185 [cit. 2018-05-03]. Dostupné z: https://www.linkos.cz/files/modra-kniha/17/649.pdf.
  6. Klener P. Současné možnosti léčby nevolnosti a zvracení. Remedia [online]. 2003, 5-2003, (3), [cit. 2018-05-03]. Dostupné z: http://www.remedia.cz/Okruhy-temat/Gastroenterologie/Soucasne-moznosti-lecby-nevolnosti-a-zvraceni/8-12-dt.magarticle.asp.
  7. Navari RM QR, Ruddy KJ. Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting, July 14, 2016, N Engl J Med 2016; 375:134-142, DOI: 10.1056/NEJMoa1515725, [cit. 2018-05-03] Dostupné z: https://www.nejm.org/doi/full/10.1056/NEJMoa1515725. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.